[Tocilizumab for refractory Takayasu arteritis with aortic aneurysm]. / Traitement par tocilizumab d'une artérite de Takayasu réfractaire avec anévrysme aortique.
J Med Vasc
; 44(3): 237-239, 2019 May.
Article
in Fr
| MEDLINE
| ID: mdl-31029281
ABSTRACT
Takayasu arteritis (TA) is a form of large vessel vasculitis (LVV) which affects the aorta and the main arteries. Many reports showed efficacy of biologic drugs (TNF α inhibitors and interleukin 6 inhibitors) in refractory TA cases. We report the case of a 46-year-old woman with refractory TA complicated by giant aortic aneurysm (AA) and severe hypertension, treated efficacy with tocilizumab (anti-interleukin 6 receptor monoclonal antibody).
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aortic Aneurysm
/
Takayasu Arteritis
/
Antibodies, Monoclonal, Humanized
/
Anti-Inflammatory Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
Fr
Journal:
J Med Vasc
Year:
2019
Document type:
Article